10 reports

  • AND FORECAST

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Colony-Stimulating Factor
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Therapeutics Development
  • Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Overview

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2017 Summary Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) pipeline Target...

  • Blood Supply
  • Breast Cancer
  • Colony-Stimulating Factor
  • Therapy
  • Amgen Inc.
  • Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Overview
  • Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Therapeutics Development

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H1 2018 Summary Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) pipeline Target constitutes close to 15 molecules. Out of which...

  • Colony-Stimulating Factor
  • Prostate Cancer
  • World
  • Product Initiative
  • OncBioMune Pharmaceuticals, Inc.
  • Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Overview
  • Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Therapeutics Development

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2018 Summary Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Granulocyte macrophage colony stimulating factor receptor subunit...

  • Blood Supply
  • Colony-Stimulating Factor
  • Therapy
  • United States
  • Product Initiative
  • Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Overview
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2018 Summary According to the recently published report ’Granulocyte Macrophage Colony Stimulating Factor - Pipeline Review, H1 2018’; Granulocyte...

  • Cancer
  • Colony-Stimulating Factor
  • United States
  • World
  • Product Initiative
  • AMG-820 - DRUG PROFILE
  • ABSK-021 - DRUG PROFILE

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H1 2018 Summary Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Macrophage colony-stimulating...

  • Colony-Stimulating Factor
  • United States
  • World
  • Company Sales
  • Product Initiative
  • AMG-820 - DRUG PROFILE
  • NUMBER OF PRODUCTS BY STAGE AND MECHANISM OF ACTIONS, H2 2017

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2017 Summary According to the recently published report ’Macrophage Colony Stimulating Factor 1 Receptor - Pipeline Review, H2 2017’; Macrophage Colony Stimulating...

  • Cancer
  • Colony-Stimulating Factor
  • United States
  • World
  • Product Initiative

MARKET ##.

  • Biological Therapy
  • Colony-Stimulating Factor
  • APAC
  • World
  • Company Sales
  • 8.2 COLONY-STIMULATING FACTORS
  • COLONY-STIMULATING FACTORS TO DOMINATE THE NORTH AMERICAN

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, and increase...

  • Colony-Stimulating Factor
  • Erythropoietin
  • North America
  • United States
  • JenKem Technology Co., Ltd

Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

  • Biological Therapy
  • Colony-Stimulating Factor
  • Business Expansion & Exit
  • Demand
  • Product Initiative